Risk of pneumonia in elderly nursing home residents using typical versus atypical antipsychotics;Riesgo de neumonía en ancianos residentes en hogares de ancianos usando antipsicóticos típicos versus atípicos

Annals of Pharmacotherapy

Volumn 47, Issue 4, 2013, Pages 464-474

  Aparasu, Rajender R ^a   Chatterjee, Satabdi ^a   Chen, Hua ^a  

^a UNIVERSITY OF HOUSTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETOPHENAZINE; ARIPIPRAZOLE; ATYPICAL ANTIPSYCHOTIC AGENT; CHLORPROMAZINE; CHLORPROTHIXENE; CLOZAPINE; FLUOXETINE PLUS OLANZAPINE; FLUPHENAZINE; HALOPERIDOL; LOXAPINE; MESORIDAZINE; MOLINDONE; NEUROLEPTIC AGENT; OLANZAPINE; PALIPERIDONE; PERPHENAZINE; PERPHENAZINEAMITRIPTYLINE; PIMOZIDE; PROMAZINE; QUETIAPINE; RISPERIDONE; THIORIDAZINE; TIOTIXENE; TRIFLUOPERAZINE; TRIFLUPROMAZINE; UNCLASSIFIED DRUG; ZIPRASIDONE;

AGED; ARTICLE; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; DATA ANALYSIS; ELDERLY CARE; FEMALE; FOLLOW UP; HAZARD RATIO; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAID; MEDICARE; MORTALITY; NURSING HOME PATIENT; PNEUMONIA; PRIORITY JOURNAL; PROPENSITY SCORE; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; RISK; UNITED STATES;

EID: 84876238880     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1R510     Document Type: Article

References (50)

1. Kamble P, Chen H, Sherer J, Aparasu RR. Antipsychotic drug use among elderly nursing home residents in the United States. Am J Geriatr Pharmacother 2008;6:187-97.
2. Chen Y, Briesacher BA, Field TS, Tjia J, Lau DT, Gurwitz JH. Unexplained variation across US nursing homes in antipsychotic prescribing rates. Arch Intern Med 2010;170:89-95.
3. Carson S, McDonagh MS, Peterson K. A systematic review of the efficacy and safety of atypical antipsychotics in patients with psychological and behavioral symptoms of dementia. J Am Geriatr Soc 2006;54:354-61.
4. Alexopoulos GS, Streim J, Carpenter D, Docherty JP; Expert Consensus Panel for Using Antipsychotic Drugs in Older Patients. Using antipsychotic agents in older patients. J Clin Psychiatry 2004;65(suppl 2):5-99.
5. Office of Inspector General, Department of Health and Human Services, Medicare Atypical Antipsychotic Drug Claims for Elderly Nursing Home Residents, OEI-07-08-00150 (May 2011), http://oig.hhs.gov/oei/ reports/oei-07-08-00150.pdf (accessed 2010 Dec 3).
6. Lieberman JA, Stroup TS, McEvoy JP, et al; Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Investigators. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med 2005;353:1209-23.
7. Jones PB, Barnes TRE, Davies L, et al. Randomized controlled trial of the effect on quality of life of second-vs first-generation antipsychotic drugs in schizophrenia: Cost Utility of the Latest Antipsychotic Drugs in Schizo-phrenia Study (CUtLASS 1). Arch Gen Psychiatry 2006;63:1079-87.
8. Food and Drug Administration Public Health Advisory: Deaths with antipsychotics in elderly patients with behavioral disturbances. http://www. fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatients andProviders/DrugSafetyInformationforHeathcareProfessionals/Public HealthAdvisories/ucm053171.htm (accessed 2010 Dec 3).
9. Food and Drug Administration Public Health Advisory. Information for healthcare professionals: conventional antipsychotics. http://www.fda. gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsand Providers/ucm124830.htm (accessed 2010 Dec 3).
10. Muder RR, Brennen C, Swenson DL, Wagener M. Pneumonia in a longterm care facility. A prospective study of outcome. Arch Intern Med 1996;156:2365-70.
11. Muder RR. Pneumonia in residents of long-term care facilities: epidemiology, etiology, management, and prevention. Am J Med 1998;105:319-30.
12. Mylotte JM. Nursing home-associated pneumonia. Clin Geriatr Med 2007;23:553-65.
13. Mehr DR, Binder EF, Kruse RL, et al. Predicting mortality in nursing home residents with lower respiratory tract infection: the Missouri LRI Study. JAMA 2001;286:2427-36.
14. Konetzka RT, Spector W, Shaffer T. Effects of nursing home ownership type and resident payer source on hospitalization for suspected pneumonia. Med Care 2004;42:1001-8.
15. Chan Carusone SB, Walter SD, Brazil K, Loeb MB. Pneumonia and lower respiratory infections in nursing home residents: predictors of hospitalization and mortality. J Am Geriatr Soc 2007;55:414-9.
16. Loeb M, Mcgeer A, McArthur M, Walter S, Simor AE. Risk factors for pneumonia and other lower respiratory tract infections in elderly residents of long-term care facilities. Arch Intern Med 1999;159:2058-64.
17. Quagliarello V, Ginter S, Han L, Van Ness P, Allore H, Tinetti M. Modifiable risk factors for nursing home-acquired pneumonia. Clin Infect Dis 2005;40:1-6.
18. Trifirò G. Antipsychotic drug use and community-acquired pneumonia. Curr Infect Dis Rep 2011;13:262-8.
19. Setoguchi S, Wang PS, Alan Brookhart M, Canning CF, Kaci L, Schneeweiss S. Potential causes of higher mortality in elderly users of conventional and atypical antipsychotic medications. J Am Geriatr Soc 2008;56:1644-50.
20. Trifirò G, Gambassi G, Sen EF, et al. Association of community-acquired pneumonia with antipsychotic drug use in elderly patients: a nested case-control study. Ann Intern Med 2010;152:418-25.
21. Knol W, van Marum RJ, Jansen PA, et al. Antipsychotic drug use and risk of pneumonia in elderly people. J Am Geriatr Soc 2008;56:661-6.
22. Star K, Bate A, Meyboom RH, Edwards IR. Pneumonia following antipsychotic prescriptions in electronic health records: a patient safety concern? Br J Gen Pract 2010;60:e385-94.
23. Barnett MJ, Perry PJ, Alexander B, Kaboli PJ. Risk of mortality associated with antipsychotic and other neuropsychiatric drugs in pneumonia patients. J Clin Psychopharmacol 2006;26:182-7.
24. Komisar HL, Feder J, Kasper JD. Unmet long-term care needs: an analysis of Medicare-Medicaid dual eligible. Inquiry 2005,42:171-82.
25. Aparasu RR, Chatterjee S, Mehta S, Chen H. Risk of death in dual-eligible nursing home residents using typical or atypical antipsychotic agents. Med Care 2012;50:961-9.
26. Centers for Medicare & Medicaid Services. Medicaid Analytic eXtract (MAX) general information. http://www.cms.hhs.gov/MedicaidData SourcesGenInfo/07_MAXGeneralInformation.asp (accessed 2010 Dec 3).
27. Research Data Assistance Center (ResDAC). Available CMS data. http:// www.resdac.umn.edu/Available_CMS_Data.asp (accessed 2010 Dec 3).
28. Centers for Medicare & Medicaid Services. Medicare Standard Analytical Files: Identifiable Data Files. http://www.cms.hhs.gov/IdentifiableData Files/02_StandardAnalyticalFiles.asp (accessed 2010 Dec 3).
29. Ray W. Evaluating medication effects outside of clinical trials: new-user designs. Am J Epidemiol 2003;158:915-20.
30. MEPS HC-052 2000 Medical Conditions, June 2003. http://www.meps. ahrq.gov/mepsweb/data_stats/download_data/pufs/h52/h52doc.pdf (accessed 2010 Dec 3).
31. Rosenbaum PR, Rubin DB. The central role of the propensity score in observational studies for causal effects. Biometrika 1983;70:41-55.
32. Brookhart MA, Schneeweiss S, Rothman KJ, et al. Variable selection for propensity score models. Am J Epidemiol 2006;163:1149-56.
33. Aparasu RR, Jano E, Johnson ML, et al. Hospitalization risk associated with typical and atypical antipsychotic use in community-dwelling elderly patients. Am J Geriatr Pharmacother 2008;6:198-204.
34. Parson LS. Reducing bias in a propensity score matched-pair sample using greedy matching techniques. http://www2.sas.com/proceedings/sugi26/ p214-26.pdf (accessed 2010 Dec 3).
35. Austin PC. Type I error rates, coverage of confidence intervals, and variance estimation in propensity-score matched analysis. Int J Biostats 2009;5:1-21.
36. Alexander MT, Kufera JA. Butting heads on matched cohort analysis using SAS software. http://www.nesug.org/proceedings/nesug07/sa/sa01.pdf (accessed 2010 Dec 3).
37. Marik PE, Kaplan D. Aspiration pneumonia and dysphagia in the elderly. Chest 2003;124:328-36.
38. Riquelme R, Torres A, El-Ebiary M, et al. Community-acquired pneumonia in the elderly: a multivariate analysis of risk and prognostic factors. Am J Respir Crit Care Med 1996;154:1450-5.
39. Stewart JT. Reversible dysphagia associated with neuroleptic treatment. J Am Geriatr Soc 2001;49:1260-1.
40. Sagar R, Varghese ST, Balhara YP. Dysphagia due to olanzapine, an antipsychotic medication. Indian J Gastroenterol 2005;24:37-8.
41. Nair S, Saeed O, Shahab H, et al. Sudden dysphagia with uvular enlargement following the initiation of risperidone which responded to benztropine: was this an extrapyramidal side effect? Gen Hosp Psychiatry 2001;23:231-2.
42. Bashford G, Bradd P. Drug-induced parkinsonism associated with dysphagia and aspiration: a brief report. J Geriatr Psychiatry Neurol 1996;9:133-5.
43. Wada H, Nakajoh K, Satoh-Nakagawa T, et al. Risk factors of aspiration pneumonia in Alzheimer's disease patients. Gerontology 2001;47:271-6.
44. Pierre JM. Extrapyramidal symptoms with atypical antipsychotics: incidence, prevention and management. Drug Saf 2005;28:191-208.
45. Jeste DV, Rockwell E, Harris MJ, et al. Conventional vs newer antipsychotics in elderly patients. Am J Geriatr Psychiatry 1999;7:70-6.
46. Miller DD. Atypical antipsychotics: sleep, sedation, and efficacy. Prim Car Companion J Clin Psychiatry 2004;6:3-7.
47. Venkatesan P, Gladman J, Macfarlane JT, et al. A hospital study of community acquired pneumonia in the elderly. Thorax 1990;45:254-8.
48. Ozbilen M, Adams CE, Marley J. Anticholinergic effects of oral antipsychotic drugs of typicals versus atypicals over medium-and long-term: systematic review and meta-analysis. Curr Med Chem 2012;19:5214-8.
49. Guevara RE, Butler JC, Marston BJ, Plouffe JF, File TM Jr, Breiman RF. Accuracy of ICD-9-CM codes in detecting community acquired pneumococcal pneumonia for incidence and vaccine efficacy studies. Am J Epidemiol 1999;149:282-9.
50. van de Garde EM, Oosterheert JJ, Bonten M, Kaplan RC, Leufkens HG. International Classification of Diseases Codes showed modest sensitivity for detecting community-acquired pneumonia. J Clin Epidemiol 2007;60: 834-8